We have a very active ALS research program here which includes (at various times) clinical trials of medications to try and slow ALS or improve symptoms, epidemiology, genetics and basic science. Our clinic director also leads the international ALSUntangled program for reviewing alternative and off label ALS treatments, and the patient and family funded ALS Reversals program, which attempts to understand why some patients with ALS get better, and to make this happen more often.
If you would like more information on any of our current clinical trials, please contact our research team via email at alsresearch@dm.duke.edu
Our current clinical trials:
Trial of Theracurmin for Patients with ALS
Status:
Enrolling, no longer recruiting
COMBAT-ALS
Status:
Enrolling and recruiting
HEALEY ALS Platform Trial
Status:
Enrolling and recruiting